The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Osteoporosis Screening Is Underutilized Despite Recommendations

Osteoporosis Screening Is Underutilized Despite Recommendations

August 15, 2017 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF

For years, guidelines from various organizations have recommended osteoporosis screening in women and men starting at a specific age or based on specific risk factors. Among these guidelines are those developed by the U.S. Preventive Services Task Force (USPSTF) that recommend universal osteoporosis screening for women 65 years of age and older and for targeted screening in all women younger than 65 years with risk factors for osteoporosis.1

You Might Also Like
  • BMI Feasible As Pre-Screening Tool for Osteoporosis in Women
  • Routine Osteoporosis Screening in Men Proves Cost-Effective
  • RA Patients May Not Receive Needed Osteoporosis Screening & Treatment
Explore This Issue
August 2017
Also By This Author
  • Months After COVID-19 Infection, Rheumatic-Like Symptoms Persist

Despite efforts to improve utilization of osteoporosis screening, data from two recent studies confirm what is now well documented: Utilization remains woefully low, even in women following a first hip fracture.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Our findings underscore the persistent failure to align real-world implementation of osteoporosis screening among older women with evidence-based guidelines,” says Catherine Gillespie, PhD, MPH, AARP Public Policy Institute, Washington, D.C.

Dr. Gillespie

Dr. Gillespie

Dr. Gillespie, along with coinvestigator Pamela E. Morin, MBA, conducted the studies to look at utilization of osteoporosis screening in two patient cohorts. Both studies looked at contemporary trends and patterns of osteoporosis screening in privately insured women in the U.S. aged 50 years and older.2,3 One study looked at utilization trends in 1,638,454 women with no prior history of osteoporosis diagnosis, drug use for osteoporosis or hip fracture.2 A second study examined trends in utilization of osteoporosis-related health services, including screening, within six to 12 months following first-time hip fracture in a cohort of 8,349 women.3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Both studies found deficiencies in how osteoporosis screening is being implemented, with each study providing important information on specific patterns of underutilization.

Primary Prevention

With the aim of describing patterns of osteo­porosis screening in U.S. women aged 50 and older with no prior history of osteoporosis, Dr. Gillespie and Ms. Morin retrospectively looked at screening rates between 2008 and 2014 among 1,638,454 U.S. women grouped into three age groups: 50–64 years, 65–79 years and 80+ years.2

The study found that overall screening rates remain low in all three age groups, with 21.1% of women screening in the 50–64-year-old age group, 26.5% in the 65–79-year-old age group, and 12.8% in women aged 80 and older. However, the study found that year-over-year changes in screening utilization in two age groups were in line with national recommendations, showing that screening rates in these age groups are moving in the right direction, says Dr. Gillespie. Although still low, screening rates increased by 38% for women aged 80 and older. For women aged 50–64 years of age, screening rates decreased by 31%, which Dr. Gillespie says is in line with the Choosing Wisely campaign that recommended against universal screening for younger women given its lack of cost effectiveness.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 | Single Page

Filed Under: Conditions Tagged With: bone density test, bone disease, bone mass, bone mineral density (BMD), Fractures, hip fracture, Osteoporosis, prevention, Research, rheumatologist, screening, underutilization, WomenIssue: August 2017

You Might Also Like:
  • BMI Feasible As Pre-Screening Tool for Osteoporosis in Women
  • Routine Osteoporosis Screening in Men Proves Cost-Effective
  • RA Patients May Not Receive Needed Osteoporosis Screening & Treatment
  • Pulse-Echo Ultrasound Useful for Osteoporosis Screening

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)